Global Enzyme Linked Immunosorbent Assay ELISA Market Overview And Scope:
Global Enzyme Linked Immunosorbent Assay ELISA Market Size was estimated at USD 185.72 million in 2022 and is projected to reach USD 230.1 million by 2028, exhibiting a CAGR of 3.64% during the forecast period.
The Global Enzyme Linked Immunosorbent Assay ELISA Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Enzyme Linked Immunosorbent Assay ELISA utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: RandD Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, EMD Millipore, BioLegend, LOEWE Biochemica, Mercodia, Cusabio, Shanghai Kehua Bio-engineering
Global Enzyme Linked Immunosorbent Assay ELISA Market Segmentation
By Type, Enzyme Linked Immunosorbent Assay ELISA market has been segmented into:Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Enzyme-Linked Immunosorbent Assay (ELISA)
By Application, Enzyme Linked Immunosorbent Assay ELISA market has been segmented into:
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Enzyme Linked Immunosorbent Assay ELISA market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Enzyme Linked Immunosorbent Assay ELISA market.
Top Key Players Covered in Enzyme Linked Immunosorbent Assay ELISA market are:
RandD Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
Objective to buy this Report:
1. Enzyme Linked Immunosorbent Assay ELISA analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Enzyme Linked Immunosorbent Assay ELISA market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Enzyme Linked Immunosorbent Assay ELISA Market by Type
5.1 Enzyme Linked Immunosorbent Assay ELISA Market Overview Snapshot and Growth Engine
5.2 Enzyme Linked Immunosorbent Assay ELISA Market Overview
5.3 Sandwich ELISA
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Sandwich ELISA: Geographic Segmentation
5.4 Indirect ELISA
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Indirect ELISA: Geographic Segmentation
5.5 Competitive ELISA
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Competitive ELISA: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
5.7 Enzyme-Linked Immunosorbent Assay (ELISA)
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Enzyme-Linked Immunosorbent Assay (ELISA): Geographic Segmentation
Chapter 6: Enzyme Linked Immunosorbent Assay ELISA Market by Application
6.1 Enzyme Linked Immunosorbent Assay ELISA Market Overview Snapshot and Growth Engine
6.2 Enzyme Linked Immunosorbent Assay ELISA Market Overview
6.3 Immunology
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Immunology: Geographic Segmentation
6.4 Inflammation
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Inflammation: Geographic Segmentation
6.5 Infectious Diseases
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Infectious Diseases: Geographic Segmentation
6.6 Cancer
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Cancer: Geographic Segmentation
6.7 Protein Quantitation
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Protein Quantitation: Geographic Segmentation
6.8 Others
6.8.1 Introduction and Market Overview
6.8.2 Historic and Forecasted Market Size (2017-2032F)
6.8.3 Key Market Trends, Growth Factors and Opportunities
6.8.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Enzyme Linked Immunosorbent Assay ELISA Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Enzyme Linked Immunosorbent Assay ELISA Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Enzyme Linked Immunosorbent Assay ELISA Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 RANDD SYSTEMS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 THERMO FISHER SCIENTIFIC
7.4 ORTHO CLINICAL DIAGNOSTICS
7.5 BD BIOSCIENCES
7.6 ZEUS SCIENTIFIC
7.7 BIO-RAD LABORATORIES
7.8 ALPCO
7.9 ENZO LIFE SCIENCES
7.10 BIOMÉRIEUX
7.11 EMD MILLIPORE
7.12 BIOLEGEND
7.13 LOEWE BIOCHEMICA
7.14 MERCODIA
7.15 CUSABIO
7.16 SHANGHAI KEHUA BIO-ENGINEERING
Chapter 8: Global Enzyme Linked Immunosorbent Assay ELISA Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Sandwich ELISA
8.2.2 Indirect ELISA
8.2.3 Competitive ELISA
8.2.4 Others
8.2.5 Enzyme-Linked Immunosorbent Assay (ELISA)
8.3 Historic and Forecasted Market Size By Application
8.3.1 Immunology
8.3.2 Inflammation
8.3.3 Infectious Diseases
8.3.4 Cancer
8.3.5 Protein Quantitation
8.3.6 Others
Chapter 9: North America Enzyme Linked Immunosorbent Assay ELISA Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Sandwich ELISA
9.4.2 Indirect ELISA
9.4.3 Competitive ELISA
9.4.4 Others
9.4.5 Enzyme-Linked Immunosorbent Assay (ELISA)
9.5 Historic and Forecasted Market Size By Application
9.5.1 Immunology
9.5.2 Inflammation
9.5.3 Infectious Diseases
9.5.4 Cancer
9.5.5 Protein Quantitation
9.5.6 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Enzyme Linked Immunosorbent Assay ELISA Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Sandwich ELISA
10.4.2 Indirect ELISA
10.4.3 Competitive ELISA
10.4.4 Others
10.4.5 Enzyme-Linked Immunosorbent Assay (ELISA)
10.5 Historic and Forecasted Market Size By Application
10.5.1 Immunology
10.5.2 Inflammation
10.5.3 Infectious Diseases
10.5.4 Cancer
10.5.5 Protein Quantitation
10.5.6 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Enzyme Linked Immunosorbent Assay ELISA Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Sandwich ELISA
11.4.2 Indirect ELISA
11.4.3 Competitive ELISA
11.4.4 Others
11.4.5 Enzyme-Linked Immunosorbent Assay (ELISA)
11.5 Historic and Forecasted Market Size By Application
11.5.1 Immunology
11.5.2 Inflammation
11.5.3 Infectious Diseases
11.5.4 Cancer
11.5.5 Protein Quantitation
11.5.6 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Enzyme Linked Immunosorbent Assay ELISA Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Sandwich ELISA
12.4.2 Indirect ELISA
12.4.3 Competitive ELISA
12.4.4 Others
12.4.5 Enzyme-Linked Immunosorbent Assay (ELISA)
12.5 Historic and Forecasted Market Size By Application
12.5.1 Immunology
12.5.2 Inflammation
12.5.3 Infectious Diseases
12.5.4 Cancer
12.5.5 Protein Quantitation
12.5.6 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Enzyme Linked Immunosorbent Assay ELISA Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Sandwich ELISA
13.4.2 Indirect ELISA
13.4.3 Competitive ELISA
13.4.4 Others
13.4.5 Enzyme-Linked Immunosorbent Assay (ELISA)
13.5 Historic and Forecasted Market Size By Application
13.5.1 Immunology
13.5.2 Inflammation
13.5.3 Infectious Diseases
13.5.4 Cancer
13.5.5 Protein Quantitation
13.5.6 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Enzyme Linked Immunosorbent Assay ELISA Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Sandwich ELISA
14.4.2 Indirect ELISA
14.4.3 Competitive ELISA
14.4.4 Others
14.4.5 Enzyme-Linked Immunosorbent Assay (ELISA)
14.5 Historic and Forecasted Market Size By Application
14.5.1 Immunology
14.5.2 Inflammation
14.5.3 Infectious Diseases
14.5.4 Cancer
14.5.5 Protein Quantitation
14.5.6 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Enzyme Linked Immunosorbent Assay ELISA Scope:
|
Report Data
|
Enzyme Linked Immunosorbent Assay ELISA Market
|
|
Enzyme Linked Immunosorbent Assay ELISA Market Size in 2025
|
USD XX million
|
|
Enzyme Linked Immunosorbent Assay ELISA CAGR 2025 - 2032
|
XX%
|
|
Enzyme Linked Immunosorbent Assay ELISA Base Year
|
2024
|
|
Enzyme Linked Immunosorbent Assay ELISA Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
RandD Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, EMD Millipore, BioLegend, LOEWE Biochemica, Mercodia, Cusabio, Shanghai Kehua Bio-engineering.
|
|
Key Segments
|
By Type
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Enzyme-Linked Immunosorbent Assay (ELISA)
By Applications
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
|
